Literature DB >> 15610699

Work-up of the functional adrenal mass.

Michael D Stifelman1, David M Fenig.   

Abstract

Evaluation of a functional adrenal mass may be initiated based on symptomatic presentation or the detection of an incidental adrenal mass. Recent literature suggests that 10% to 20% of adrenal incidentalomas demonstrate subclinical hormonal dysfunction, which may place patients at a higher risk for metabolic or cardiovascular disorders. Many diagnostic algorithms have been proposed for the evaluation of pheochromocytoma, Cushing's adenoma, aldosteronoma, and hormonally active adrenal cortical carcinoma. In this article, the available literature on functional adrenal masses is reviewed and up-to-date methods of efficient diagnosis are proposed.

Entities:  

Mesh:

Year:  2005        PMID: 15610699     DOI: 10.1007/s11934-005-0069-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  30 in total

Review 1.  Adrenocortical carcinoma: diagnosis, evaluation and treatment.

Authors:  Linda Ng; John M Libertino
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

Review 2.  Primary aldosteronism.

Authors:  R D Gordon
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

Review 3.  Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma.

Authors:  Ioannis Ilias; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

4.  FEMINIZING ADRENOCORTICAL TUMORS IN THE MALE. A REVIEW OF 52 CASES INCLUDING A CASE REPORT.

Authors:  J L GABRILOVE; D C SHARMA; H H WOTIZ; R I DORFMAN
Journal:  Medicine (Baltimore)       Date:  1965-01       Impact factor: 1.889

Review 5.  Hormonal evaluation of the patient with an incidentally discovered adrenal mass.

Authors:  N S Ross; D C Aron
Journal:  N Engl J Med       Date:  1990-11-15       Impact factor: 91.245

6.  The changing clinical spectrum of primary aldosteronism.

Authors:  E L Bravo; R C Tarazi; H P Dustan; F M Fouad; S C Textor; R W Gifford; D G Vidt
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

7.  Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

Authors:  B Shapiro; J E Copp; J C Sisson; P L Eyre; J Wallis; W H Beierwaltes
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

8.  Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.

Authors:  L E Quint; G M Glazer; I R Francis; B Shapiro; T L Chenevert
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

Review 9.  Clinical manifestation of aldosteronoma.

Authors:  Maha Al Fehaily; Quan-Yang Duh
Journal:  Surg Clin North Am       Date:  2004-06       Impact factor: 2.741

10.  Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.

Authors:  J P Luton; S Cerdas; L Billaud; G Thomas; B Guilhaume; X Bertagna; M H Laudat; A Louvel; Y Chapuis; P Blondeau
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

View more
  3 in total

Review 1.  Skeletal muscle insulin resistance in endocrine disease.

Authors:  Melpomeni Peppa; Chrysi Koliaki; Panagiotis Nikolopoulos; Sotirios A Raptis
Journal:  J Biomed Biotechnol       Date:  2010-03-15

2.  Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal Adenomas.

Authors:  Giuseppe Reimondo; Barbara Allasino; Marcella Coletta; Anna Pia; Giulia Peraga; Barbara Zaggia; Chiara Massaglia; Piero Paccotti; Massimo Terzolo
Journal:  Int J Endocrinol       Date:  2015-05-14       Impact factor: 3.257

3.  The case series of functional adrenal tumors: Experience of two tertiary hospitals in Yaoundé, Cameroon.

Authors:  L O Mbouché; F G Epoupa Ngallé; Z Sando; S P Choukem; F F Angwafo
Journal:  Int J Surg Case Rep       Date:  2020-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.